Classification: Pharmaceutical Intermediates
Cas NO.: 1062580-52-2
Molecular Formula: C14H24Cl2N2
Melting Point: 249?251?
Tofacitinib Citrate Intermediate. Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.